Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia

NCT00537953 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Cutaneous Leihmaniasis

Interventions

DRUG: Miltefosine , meglumine antimoniate

Sponsor

Centro de Investigaciones Bioclínicas de la Fundación Fader